Am J Manag Care
-
Publication Venue For
- Potential impact of pharmaceutical industry rebates on medication adherence.. 25:e135-e137. 2019
- Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".. 25:171-172. 2019
- Value-based arrangements may be more prevalent than assumed.. 25:70-76. 2019
- Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. 24:S138-S145. 2018
- Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.. 24:S138-S145. 2018
- Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population. 24:S146-S155. 2018
- Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.. 24:S146-S155. 2018
- Trends in hospital-physician integration in medical oncology.. 23:624-627. 2017
- Evaluation of a packaging approach to improve cholesterol medication adherence.. 23:e280-e286. 2017
- Health insurance and racial disparities in pulmonary hypertension outcomes.. 23:474-480. 2017
- Risk stratification for return emergency department visits among high-risk patients.. 23:e275-e279. 2017
- Perceptions of the medical home by parents of children with chronic illnesses.. 23:e70-e74. 2017
- Does distance modify the effect of self-testing in oral anticoagulation?. 22:65-71. 2016
- The utility of cost discussions between patients with cancer and oncologists.. 21:607-615. 2015
- Worksite medical home: health services use and claim costs.. 21:e422-e429. 2015
- Stimulating comprehensive medication reviews among Medicare Part D beneficiaries.. 21:e372-e378. 2015
- Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus.. 21:e235-e243. 2015
- Predicting nursing home placement among home- and community-based services program participants.. 20:e535-e536. 2014
- Massachusetts health reform and Veterans Affairs health system enrollment.. 20:629-636. 2014
- Removing a constraint on hospital utilization: a natural experiment in Maryland.. 20:e191-e199. 2014
- The how and why of stress, diabetes, and the brain.. 20:E3. 2014
- Variability in resource use: diagnosing colorectal cancer.. 19:370-376. 2013
- Short-term costs associated with primary prophylactic G-CSF use during chemotherapy.. 19:150-159. 2013
- Patient safety-focused medication therapy management: challenges affecting future implementation.. 18:e238-e244. 2012
- Medication adherence changes following value-based insurance design.. 18:265-274. 2012
- Emergency department visits in Veterans Affairs medical facilities.. 17:e215-e223. 2011
- Risk adjustment for Medicare beneficiaries with Alzheimer's disease and related dementias.. 16:191-198. 2010
- Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.. 16:e20-e34. 2010
- Innovative health reform models: pay-for-performance initiatives.. 15:S300-S305. 2009
- Variation in the cost of medications for the treatment of colorectal cancer.. 14:717-725. 2008
- Health system correlates of receipt of radiation therapy after breast-conserving surgery: a study of low-income Medicaid-enrolled women.. 14:644-652. 2008
- Optimal cancer care across the spectrum of life and disease.. 14:262-264. 2008
- Current management of glaucoma and the need for complete therapy.. 14:S20-S27. 2008
- Making it happen: managed care considerations in vanquishing hepatitis C.. 13 Suppl 12:S327-S336. 2007
- Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.. 13:530-534. 2007
- Can We Continue to Afford Organ Transplants in an Era of Managed Care?. 2:293-297. 1996